{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:36:12Z","timestamp":1793723772053,"version":"4.6.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002915","name":"FRM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001961","name":"AXA Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012126","name":"Alzheimer's Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012126","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021790","name":"Fondation Recherche Alzheimer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021790","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ebiom.2025.105805","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T09:50:42Z","timestamp":1749721842000},"page":"105805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Comparative performance of plasma pTau181\/A\u03b242, pTau217\/A\u03b242 ratios, and individual measurements in detecting brain amyloidosis"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6117-562X","authenticated-orcid":false,"given":"Sylvain","family":"Lehmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Gabelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Duchiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germain","family":"Busto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Morchikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8606-6814","authenticated-orcid":false,"given":"Constance","family":"Delaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Hirtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3235-3740","authenticated-orcid":false,"given":"Etienne","family":"Mondesert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Cristol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Barnier-Figue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Perrein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Turpinat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snejana","family":"Jurici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Bennys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ebiom.2025.105805_bib1","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","article-title":"Biomarker modeling of Alzheimer's disease","volume":"80","author":"Jack","year":"2013","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105805_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026380","article-title":"What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France","volume":"9","author":"Cognat","year":"2019","journal-title":"BMJ Open"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105805_bib3","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's association workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105805_bib4","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/jamaneurol.2024.3770","article-title":"Alzheimer disease as a clinical-biological construct-an international working group recommendation","volume":"81","author":"Dubois","year":"2024","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105805_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105805_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105805_bib7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105805_bib8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00401-013-1185-7","article-title":"Cerebral amyloid PET imaging in Alzheimer's disease","volume":"126","author":"Jack","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"14","key":"10.1016\/j.ebiom.2025.105805_bib9","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1212\/WNL.0000000000001991","article-title":"Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease","volume":"85","author":"Palmqvist","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105805_bib10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13024-024-00755-3","article-title":"Clarifying the association of CSF Abeta, tau, BACE1, and neurogranin with AT(N) stages in Alzheimer disease","volume":"19","author":"Lehmann","year":"2024","journal-title":"Mol Neurodegener"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105805_bib11","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/alz.13609","article-title":"Individuals with Alzheimer's disease and low tau burden: characteristics and implications","volume":"20","author":"Landau","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105805_bib12","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105805_bib13","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","article-title":"Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic","volume":"14","author":"Hampel","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105805_bib14","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jamaneurol.2021.3180","article-title":"Head-to-Head comparison of 8 plasma amyloid-beta 42\/40 assays in Alzheimer disease","volume":"78","author":"Janelidze","year":"2021","journal-title":"JAMA Neurol"},{"issue":"17","key":"10.1016\/j.ebiom.2025.105805_bib15","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1212\/WNL.0000000000003246","article-title":"Plasma tau in Alzheimer disease","volume":"87","author":"Mattsson","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105805_bib16","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/brain\/awac333","article-title":"Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease","volume":"146","author":"Janelidze","year":"2023","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105805_bib17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/jnnp-2022-330540","article-title":"Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function","volume":"94","author":"Lehmann","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105805_bib18","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/clinchem\/hvad103","article-title":"Head-to-Head comparison of two plasma Phospho-tau assays in predicting conversion of mild cognitive impairment to dementia","volume":"69","author":"Lehmann","year":"2023","journal-title":"Clin Chem"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105805_bib19","article-title":"Mass spectrometry follow-up of t181, s199, s202, t205, and T217 tau phosphorylation in cerebrospinal fluid from patients revealed a specific Alzheimer's disease pattern","volume":"11","author":"Barthelemy","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105805_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13195-020-00596-4","article-title":"Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification","volume":"12","author":"Barthelemy","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105805_bib21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41591-020-0781-z","article-title":"A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease","volume":"26","author":"Barthelemy","year":"2020","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105805_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13195-024-01513-9","article-title":"Diagnostic performance of plasma pTau(217), pTau(181), Abeta(1-42) and Abeta(1-40) in the LUMIPULSE automated platform for the detection of Alzheimer disease","volume":"16","author":"Arranz","year":"2024","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105805_bib23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","article-title":"Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology","volume":"81","author":"Ashton","year":"2024","journal-title":"JAMA Neurol"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105805_bib24","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jamaneurol.2024.2619","article-title":"Plasma phosphorylated tau 217 and Abeta42\/40 to predict early brain Abeta Accumulation in People without cognitive impairment","volume":"81","author":"Janelidze","year":"2024","journal-title":"JAMA Neurol"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105805_bib25","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/jnnp-2024-333467","article-title":"Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment","volume":"95","author":"Lehmann","year":"2024","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105805_bib26","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41591-022-01822-2","article-title":"Performance of plasma phosphorylated tau 181 and 217 in the community","volume":"28","author":"Mielke","year":"2022","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105805_bib27","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s43587-023-00471-5","article-title":"A two-step workflow based on plasma p-tau217 to screen for amyloid beta positivity with further confirmatory testing only in uncertain cases","volume":"3","author":"Brum","year":"2023","journal-title":"Nat Aging"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105805_bib28","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/alz.12510","article-title":"Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease-related blood-based biomarkers: results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group","volume":"18","author":"Verberk","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105805_bib29","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/alz.12949","article-title":"Plasma Abeta42\/Abeta40 ratio is independent of renal function","volume":"19","author":"Lehmann","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105805_bib30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jamaneurol.2023.4719","article-title":"Effect of Neprilysin inhibition on Alzheimer disease plasma biomarkers: a secondary analysis of a randomized clinical trial","volume":"81","author":"Brum","year":"2024","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105805_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1515\/cclm-2021-0651","article-title":"Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid","volume":"60","author":"Gobom","year":"2022","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105805_bib32","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1002\/alz.13764","article-title":"Clinical validation of the PrecivityAD2 blood test: a mass spectrometry-based test with algorithm combining %p-tau217 and Abeta42\/40 ratio to identify presence of brain amyloid","volume":"20","author":"Meyer","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105805_bib33","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2217\/bmm.12.46","article-title":"Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update","volume":"6","author":"del Campo","year":"2012","journal-title":"Biomark Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105805_bib34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13195-019-0485-0","article-title":"Advantages and disadvantages of the use of the CSF Amyloid beta (Abeta) 42\/40 ratio in the diagnosis of Alzheimer's disease","volume":"11","author":"Hansson","year":"2019","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105805_bib35","article-title":"Comparing CSF amyloid-beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status","volume":"13","author":"Willemse","year":"2021","journal-title":"Alzheimers Dement (Amst)"},{"issue":"19","key":"10.1016\/j.ebiom.2025.105805_bib36","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-Based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105805_bib37","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/alz.12751","article-title":"An accurate fully automated panel of plasma biomarkers for Alzheimer's disease","volume":"19","author":"Palmqvist","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105805_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10654-019-00494-6","article-title":"Principles of confounder selection","volume":"34","author":"VanderWeele","year":"2019","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105805_bib39","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105805_bib40","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/alz.12301","article-title":"Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study","volume":"17","author":"Brickman","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105805_bib41","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/s41467-020-15436-0","article-title":"Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease","volume":"11","author":"Janelidze","year":"2020","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105805_bib42","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41582-024-00977-5","article-title":"Acceptable performance of blood biomarker tests of amyloid pathology \u2014 recommendations from the Global CEO Initiative on Alzheimer's Disease","volume":"20","author":"Schindler","year":"2024","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105805_bib43","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/s41591-024-02869-z","article-title":"Highly accurate blood test for Alzheimer's disease comparable or superior to clinical CSF tests","volume":"30","author":"Barthelemy","year":"2024","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105805_bib44","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3233\/JAD-160865","article-title":"Cerebrospinal fluid Abeta42\/Abeta40 as a means to limiting tube- and storage-dependent pre-analytical variability in clinical setting","volume":"57","author":"Gervaise-Henry","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.ebiom.2025.105805_bib45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fneur.2015.00247","article-title":"Cerebrospinal fluid Abeta40 improves the interpretation of Abeta42 concentration for diagnosing Alzheimer's disease","volume":"6","author":"Dorey","year":"2015","journal-title":"Front Neurol"},{"issue":"5 Suppl","key":"10.1016\/j.ebiom.2025.105805_bib46","first-page":"S390","article-title":"Impact of harmonization of collection tubes on Alzheimer's disease diagnosis","volume":"10","author":"Lehmann","year":"2013","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105805_bib47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13195-020-00696-1","article-title":"Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer's disease and are highly correlated with phospho-tau in control individuals","volume":"12","author":"Lehmann","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105805_bib48","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/alz.12510","article-title":"Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease-related blood-based biomarkers: results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group","volume":"18","author":"Verberk","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105805_bib49","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1002\/alz.12897","article-title":"Robustness of CSF Abeta42\/40 and Abeta42\/P-tau181 measured using fully automated immunoassays to detect AD-related outcomes","volume":"19","author":"Leuzy","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105805_bib50","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","article-title":"CSF biomarkers of Alzheimer's disease concord with amyloid-beta PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts","volume":"14","author":"Hansson","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105805_bib51","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2174\/1567205016666190725150836","article-title":"The CSF p-tau181\/Abeta42 ratio offers a good accuracy \"in vivo\" in the differential diagnosis of Alzheimer's dementia","volume":"16","author":"Santangelo","year":"2019","journal-title":"Curr Alzheimer Res"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105805_bib52","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209866","article-title":"Lumipulse-measured cerebrospinal fluid biomarkers for the early detection of Alzheimer disease","volume":"103","author":"Safransky","year":"2024","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105805_bib53","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/alz.12332","article-title":"Plasma P-tau181 to Abeta42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular disease","volume":"17","author":"Chong","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105805_bib54","article-title":"Plasma p-tau181\/Abeta(1-42) ratio predicts Abeta-PET status and correlates with CSF-p-tau181\/Abeta(1-42) and future cognitive decline","volume":"14","author":"Fowler","year":"2022","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105805_bib55","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3233\/JAD-180321","article-title":"Plasma Abeta42 as a biomarker of prodromal Alzheimer's disease progression in patients with amnestic mild cognitive impairment: evidence from the PharmaCog\/E-ADNI study","volume":"69","author":"Albani","year":"2019","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105805_bib56","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/s41591-022-02074-w","article-title":"Differential roles of Abeta42\/40, p-tau231 and p-tau217 for Alzheimer's trial selection and disease monitoring","volume":"28","author":"Ashton","year":"2022","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105805_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14430","article-title":"Influence of medical conditions on the diagnostic accuracy of plasma p-tau217 and p-tau217\/Abeta42","volume":"21","author":"Olvera-Rojas","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105805_bib58","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13195-024-01469-w","article-title":"Combining plasma Abeta and p-tau217 improves detection of brain amyloid in non-demented elderly","volume":"16","author":"Niimi","year":"2024","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105805_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14536","article-title":"Plasma p-tau217 and p-tau217\/Abeta1-42 are effective biomarkers for identifying CSF- and PET imaging-diagnosed Alzheimer's disease: insights for research and clinical practice","volume":"21","author":"Zhong","year":"2025","journal-title":"Alzheimers Dement"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642500249X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642500249X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T16:16:22Z","timestamp":1762618582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235239642500249X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":59,"alternative-id":["S235239642500249X"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105805","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.12.07.24318640","asserted-by":"object"}]},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative performance of plasma pTau181\/A\u03b242, pTau217\/A\u03b242 ratios, and individual measurements in detecting brain amyloidosis","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105805"}}